PRIVATE EQUITY

QUALITY AND SAFE MEDICAL PRODUCTS AND EQUIPMENT

Any company is committed to its clients and its suppliers. The difference between Richdale Ventures and its competition is that we ready to invest our own financial resources in the future of our partners up and down the chain. When we sub-license a product, our focus is not only to maximizing our share of the royalties. We are most interested in accompanying the IP owner in its product life journey.

Our ideal target companies have at least two years of sales records with revenues ranging between $200,000 - $1,000,000 USD.